DR Reddys Laboratories Limited Capecitabine Export Data — India (DGFT 2022–2026)

Name: DR Reddys Laboratories Limited Capecitabine Export Records India — #11 Exporter, 13 Shipments, $650.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Capecitabine

India Pharmaceutical Trade Intelligence

$88.6M216 Suppliers123 CountriesHS 30049049

ExportsIndia → UNITED STATES71.0%India → RUSSIA3.8%

ImportsGERMANY → India$15.9M MALAYSIA → India$1.8K

#1 Supplier: MANKIND PHARMA #1 Buyer: LIFESTAR PHARMA

DR Reddys Laboratories Limited — Capecitabine Exporter #11 | $650.0K Trade Value | TransData Nexus | TransData Nexus

DR Reddys Laboratories Limited — Capecitabine Exporter Profile

Indian Pharmaceutical Exporter · #11 for Capecitabine · $650.0K export value · DGFT Verified

DR Reddys Laboratories Limited is the #11 Indian exporter of Capecitabine with $650.0K in export value and 13 verified shipments. DR Reddys Laboratories Limited holds a 0.7% market share in Capecitabine exports across 4 countries. The company exports 37 pharmaceutical products worth $62.4M across 17 therapeutic categories.

DR Reddys Laboratories Limited — Capecitabine Export Profile: Buyers & Destinations

DR Reddys Laboratories Limited Capecitabine export treemap — buyers and destination countries | TransData Nexus

Where Does DR Reddys Laboratories Limited Export Capecitabine?

Country	Value	Shipments	Share
UNITED STATES	$316.4K	7	61.0%
UNITED KINGDOM	$150.0K	3	28.9%
AUSTRALIA	$51.9K	2	10.0%
UZBEKISTAN	$36	1	0.0%

Who Are the Top Buyers of Capecitabine from DR Reddys Laboratories Limited?

Buyer	Country	Value	Orders
DR REDDYS LABORATORIES INC	UNITED STATES	$266.4K	6
DR REDDY S LABORATORIES UK LTD	UNITED KINGDOM	$100.0K	2
DR REDDY S LABORATORIES INC	UNITED STATES	$50.0K	1
DR REDDYS S LABORATORIES U K LIMITED	UNITED KINGDOM	$50.0K	1
DR REDDY S LABORATORIES AUSTRALIA PTY LTD	AUSTRALIA	$45.6K	1
DR REDDY S LABORATORIES AUSTRALIA P L	AUSTRALIA	$6.4K	1
STATE CENTRE OF EXPERTIZE AND	UZBEKISTAN	$36	1

DR Reddys Laboratories Limited supplies Capecitabine to 7 buyers globally. The largest buyer is DR REDDYS LABORATORIES INC (UNITED STATES), followed by DR REDDY S LABORATORIES UK LTD (UNITED KINGDOM) and DR REDDY S LABORATORIES INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Capecitabine Formulations Does DR Reddys Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
CAPECITABINE TABS USP 500 MG 120'S USA	$200.0K	4
CAPECITABINE TABS USP 150 MG 60'S USA	$116.4K	3
CAPECITABINE FC TAB 500MG 120S12X10SUK	$100.0K	2
CAPECITABINE FC TAB 500MG 120S	$50.0K	1
CAPECITABINE-DRLA 500 FCTAB 120 AUS	$45.6K	1
CAPECITABINE-DRLA 150 FCTAB 60 AUS	$6.4K	1
CAPECITABINE TABLETS USP 500 MG KAPFURO	$36	1

DR Reddys Laboratories Limited exports 7 distinct Capecitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CAPECITABINE TABS USP 500 MG 120'S USA with 4 shipments worth $200.0K.

How Does DR Reddys Laboratories Limited Compare to Nearest Capecitabine Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
10	NAPROD LIFE SCIENCES PRIVATE LIMITED	$946.4K	27	5	$35.1K
12	BETA DRUGS LIMITED	$708.5K	124	12	$5.7K
11	DR REDDYS LABORATORIES LIMITED ★	$650.0K	13	4	$50.0K
13	BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED	$599.5K	17	3	$35.3K
14	CIPLA LIMITED	$596.3K	18	4	$33.1K

DR Reddys Laboratories Limited ranks #11 among 216 Indian Capecitabine exporters. Average shipment value of $50.0K compared to the market average of $148.1K. The closest competitors by value are NAPROD LIFE SCIENCES PRIVATE LIMITED and BETA DRUGS LIMITED.

Which Indian Ports Ship Capecitabine Exports?

Port	Shipments	% Share
SAHAR AIR	359	16.0%
SAHAR AIR CARGO ACC (INBOM4)	283	12.6%
DELHI AIR CARGO ACC (INDEL4)	233	10.4%
HYDERABAD ICD (INSNF6)	173	7.7%
HYDERABAD AIR	154	6.9%
DELHI AIR	142	6.3%
HYDERABAD ACC (INHYD4)	89	4.0%
Bombay Air	80	3.6%

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Capecitabine Exports

The global pharmaceutical export landscape has been significantly influenced by recent geopolitical events. The 2026 Strait of Hormuz crisis, initiated by military conflicts involving the United States, Israel, and Iran, led to the effective halt of shipping traffic through this critical maritime route, disrupting approximately 20% of the world's daily oil supply and causing a surge in global energy prices. (en.wikipedia.org) This disruption has had a cascading effect on shipping costs and insurance premiums, directly impacting Indian pharmaceutical exporters like Dr. Reddy's, which rely on these routes for timely delivery of products to key markets.

Simultaneously, the 2025–26 United States–India diplomatic and trade crisis, marked by the imposition of a 50% tariff on Indian exports by the U.S., has posed additional challenges. These tariffs have increased the cost of Indian pharmaceutical products in the U.S. market, potentially affecting the competitiveness of companies like Dr. Reddy's. (en.wikipedia.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. Dr. Reddy's has been proactive in adhering to these regulations, ensuring that its products meet the stringent safety and traceability standards mandated by the EU, thereby maintaining its market access and reputation.

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Dr. Reddy's has demonstrated a commitment to quality by securing approvals from major regulatory bodies, including the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). The company's recent Biologics License Application (BLA) submission for a proposed interchangeable biosimilar to Orencia® (abatacept) underscores its adherence to rigorous regulatory processes. (stockwatch.com)

However, the company has faced regulatory challenges, such as the tax audit decision from the Russian Federal Tax Service in January 2026, which reclassified certain marketing services as taxable, resulting in a penalty. (stocktitan.net) Such incidents highlight the complexities of operating in diverse regulatory environments and the importance of robust compliance frameworks.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Capecitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: DR Reddys Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 13 individual customs records matching DR Reddys Laboratories Limited exporting Capecitabine, covering 7 formulations to 4 countries via 7 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 123+ countries, 516+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Capecitabine

Capecitabine

DR Reddys Laboratories Limited — Capecitabine Exporter Profile

DR Reddys Laboratories Limited — Capecitabine Export Profile: Buyers & Destinations

Where Does DR Reddys Laboratories Limited Export Capecitabine?

Who Are the Top Buyers of Capecitabine from DR Reddys Laboratories Limited?

What Is India's Total Capecitabine Export Value and How Much Does DR Reddys Laboratories Limited Contribute?

What Is the Average Shipment Value for DR Reddys Laboratories Limited's Capecitabine Exports?

How Does DR Reddys Laboratories Limited Compare to Other Indian Capecitabine Exporters?

What Capecitabine Formulations Does DR Reddys Laboratories Limited Export?

Regulatory Requirements: Exporting Capecitabine to Key Markets

United States — FDA

United Kingdom — MHRA

Australia — TGA

How Does DR Reddys Laboratories Limited Compare to Nearest Capecitabine Exporters?

Which Indian Ports Ship Capecitabine Exports?

What Other Advanced Oncology Products Does DR Reddys Laboratories Limited Export?

Geopolitical & Trade Policy Impact on DR Reddys Laboratories Limited's Capecitabine Exports

DR Reddys Laboratories Limited — Regulatory Compliance & Quality Standards

About DR Reddys Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Capecitabine Export Data from DR Reddys Laboratories Limited

Capecitabine Stats

Company Overview

Top Products by DR Reddys Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source